Vasodilator Peptides: CGRP, Substance P, and Adrenomedullin

Hypertension

Volumn , Issue , 2005, Pages 193-202

  Watson, Ralph E ^a   DiPette, Donald J ^b   Supowit, Scott C ^b   Katki, Khurshed A ^b   Zhao, Huawei ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857212304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0258-5.50109-5     Document Type: Chapter

References (95)

1. Amara SG, Jonas V, Rosenfeld MG, et al. Alternative RNA processing in calcitonin gene expression generates mRNA encoding different polypeptide products. Nature 1982, 298:240-244.
2. Rosenfeld MG, Mermod JJ, Amara SG, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 1983, 304:129-133.
3. Wimalawansa SJ Calcitonin gene-related peptide and its receptors: Molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocrine Rev 1996, 17:533-585.
4. Breimer LH, MacIntyre I, Zaidi M Peptides from the calcitonin genes: Molecular genetics, structure, and function. Biochem J 1988, 255:377-390.
5. Dockray GJ Physiology of enteric neuropeptides. Physiology of the Gastrointestinal Tract 1994, 169. Raven Press, New York. L.R. Johnson (Ed.).
6. Yaksh TL, Bailey SB, Roddy DR Peripheral release of substance P from primary afferents. Proceedings of the Vth World Congress on Pain 1988, 51. Elsevier, Amsterdam. R. Dubner, G.F. Gebhart, M.R. Bond (Eds.).
7. DiPette DJ, Supowit SC Calcitonin gene-related peptide and hypertension. Hypertension: A Companion to Brenner and Rector's The Kidney 2000, 182-189. WB Saunders, Philadelphia. S. Oparil, M.A. Weber (Eds.).
8. Asimakis GK, DiPette DJ, Conti VR, et al. Hemodynamic action of calcitonin gene-related peptide in the isolated rat heart. Life Sci 1987, 41:597-603.
9. DiPette DJ, Schwarzenberger K, Kerr N, et al. Dose dependent systemic and regional hemodynamic effects of calcitonin gene-related peptide. Am J Med Sci 1989, 297:65-70.
10. Brain SD, Williams TJ, Tippins JR, et al. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985, 313:54-56.
11. Supowit SC, Guraraj A, Ramana CV, et al. Enhanced neuronal expression of calcitonin gene-related peptide in mineralocorti-coid-salt hypertension. Hypertension 1995, 25:1333-1338.
12. Supowit SC, Zhao H, Hallman DM, et al. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat. Hypertension 1997, 29:945-950.
13. Supowit SC, Zhao H, Hallman DM, et al. Calcitonin gene-related peptide is a depressor in subtotal nephrectomy hypertension. Hypertension 1998, 31:391-396.
14. Gangula PR, Supowit SC, Wimalawansa SJ, et al. Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester (L-NAME)-induced preeclampsia. Hypertension 1997, 29:248-253.
15. Watson RE, DiPette DJ Experimental models of hypertension. Hypertension Primer: The Essentials of High Blood Pressure, 3rd ed 2002, Lippincott Williams & Wilkins, Baltimore. J.L. Izzo, H.R. Black (Eds.).
16. Supowit SC, Zhao H, DiPette DJ Nerve growth factor enhances calcitonin gene-related peptide expression in the spontaneously hypertensive rat. Hypertension 2001, 37:728-732.
17. Watson RE, Supowit SC, Zhao H, et al. Role of sensory nervous system vasoactive peptides in hypertension. Braz J Med Biol Res 2002, 35:1033-1045.
18. Hoff AO, Thomas PM, Cote GJ, et al. Generation of a calcitonin knockout mouse model [Abstract]. Bone 1998, 23:S64.
19. Gangula PR, Zhao H, Supowit SC, et al. Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. Hypertension 2000, 35:470-475.
20. Carlson SH, Wyss MJ Long-term telemetric recording of arterial pressure and heart rate in mice fed nasal and high NaCl diets. Hypertension 2000, 35:1-11.
21. DiPette DJ, Wimalawansa SJ Cardiovascular actions of calcitonin gene-related peptide. Calcium Regulating Hormones and Cardiovascular Function 1994, 239. MI, CRC Press, Ann Arbor. J. Crass, L.V. Avioli (Eds.).
22. Lu JT, Son YT, Lee J, et al. Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol Cell Neurosci 1999, 14:99-120.
23. Oh-hashi Y, Shindo T, Kurihara Y, et al. Elevated sympathetic nervous activity in mice deficient in alpha-CGRP. Circ Res 2001, 89:983-990.
24. Supowit SC, Zhao H, Watson RE, et al. The blood pressure increase in deoxycorticosterone-salt-induced hypertension is enhanced in alpha-calcitonin gene-related peptide null mice [Abstract]. Am J Hypertens 2002, 15:183A.
25. Zhao H, Supowit SC, Li J, et al. Capsaicin-induced hypotension: Role of calcitonin gene-related peptide [Abstract]. FACEB J 2002, 16:A831.
26. Ma H, Huang R, Abela GS, et al. Coronary flow is decreased in the alpha-calcitonin gene-related peptide knockout mouse [Abstract]. Hypertension 2002, 40:384.
27. Lembeck F, Holzer P Substance P as a neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 1979, 310:175-183.
28. Holzer P Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide, and other neuropeptides. Neuroscience 1988, 45:739-768.
29. Stewart-Lee A, Burnstock G Actions of tachykinins in the rabbit mesenteric artery: Substance P and [Glp6,L-Pro9]SP6-11 are potent agonists for endothelial neurokinin-1 receptors. Br J Pharmacol 1989, 97:1218-1224.
30. von Euler US, Gaddum JH An unidentified depressor substance in certain tissue extracts. J Physiol (Lond) 1931, 72:74-87.
31. Chang MM, Leeman SE, Nial HD Amino acid sequence of substance P. Nature New Biol 1971, 232:86-87.
32. Hokfelt T, Broberger C, Xu ZQ, et al. Neuropeptides: An overview. Neuropharmacology 2000, 39:1337-1356.
33. MacDonald MR, Takeda J, Rice CM, et al. Multiple tachykinins are produced and secreted upon post-translational processing of the three substance P precursor proteins, alpha-, beta-, and gamma-preprotachykinin. Expression of the preprotachykinins in AtT-20 cells infected with vaccinia virus recombinants. J Biol Chem 1989, 264:15578-15592.
34. Hokfelt T, Pernow B, Wahren J Substance P: A pioneer amongst neuropeptides. J Intern Med 2001, 249:27-40.
35. Maggi CA The mammalian tachykinin receptors. Gen Pharmacol 1995, 26:911-944.
36. Mau SE Effects of substance P on cellular signaling systems in the rat anterior pituitary. Danish Med Bull 1999, 46:35-56.
37. Ribeiro da Silva A, Hokfelt T Neuroanatomical localisation of substance P in the CNS and sensory neurons. Neuropeptides 2000, 34:256-271.
38. Marti E, Gibson SJ, Polak JM, et al. Ontogeny of peptide-and-amine-containing neurones in motor, sensory and autonomic regions of rat and human spinal cord, dorsal root ganglia and rat skin. J Comp Neurol 1987, 226:332-359.
39. Rang HP, Bevan SJ, Dray A Nociceptive peripheral neurones: Cellular properties. Textbook of Pain 1994, 57-78. Churchill-Livingstone, Edinburgh. P.D. Wall, R. Melzak (Eds.).
40. Holzer P, Maggi CA Dissociation of dorsal root ganglion neurons into afferent and efferent-like neurons. Neuroscience 1998, 86:389-398.
41. Kohlmann O, Cesaretti ML, Ginoza M, et al. Role of substance P in blood pressure regulation in salt-dependent experimental hypertension. Hypertension 1997, 29:506-509.
42. Katki KA, Supowit SC, DiPette DJ Substance P in subtotal nephrectomy-salt hypertension. Hypertension 2002, 39(part 2):389-393.
43. Katki KA, Supowit SC, DiPette DJ Enhanced expression of substance P in deoxycorticosterone acetate-induced hypertension [Abstract]. Circulation 2000, 102(Suppl II):II348-II349.
44. Katki KA, Supowit SC, DiPette DJ Role of calcitonin gene-related peptide and substance P in Dahl-salt hypertension. Hypertension 2001, 38(part 2):679-682.
45. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochro-mocytoma. Biochem Biophys Res Commun 1993, 192:553-560.
46. Champion HC, Nussdorfer GG, Kadowitz PJ Structure-activity relationships of adrenomedullin in the circulation and adrenal gland. Regul Pept 1999, 85:1-8.
47. Jougasaki M, Burnett JC Adrenomedullin: Potential in physiology and pathophysiology. Life Sci 2000, 66:855-872.
48. Sakata J, Shimokubo T, Kitamura K, et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett 1994, 352:105-108.
49. Ichiki Y, Kitamura K, Kangawa K, et al. Distribution and characterization of immunoreactive adrenomedullin in porcine tissue, and isolation of adrenomedullin [26-52] and adrenomedullin [34-52] from porcine duodenum. J Biochem (Tokyo) 1995, 118:765-770.
50. Sugo S, Minamino N, Kangawa K, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994, 201:1160-1166.
51. Hinson JP, Kapas S, Smith DM Adrenomedullin, a multifunctional regulatory peptide. Endocrine Rev 2000, 21:138-167.
52. Kohno M, Hanehira T, Kano H, et al. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996, 27:102-107.
53. Tanaka M, Kitamura K, Ishizaka Y, et al. Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects. Intern Med (Tokyo) 1995, 34:728-733.
54. Letizia C, Subioli S, Cerci S, et al. High plasma adrenomedullin concentrations in patients with high-renin essential hypertension. J Renin Angiotensin Aldosterone Syst 2002, 3:126-129.
55. Kitamura K, Ichiki Y, Tanaka M, et al. Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994, 341:288-290.
56. Cheung B, Leung R Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci (Lond) 1997, 92:59-62.
57. Ishimitsu T, Nishikimi T, Saito Y, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994, 94:2158-2161.
58. Ishimitsu T, Nishikimi T, Matsuoka H, et al. Behavior of adrenomedullin during acute and chronic salt loading in nor-motensive and hypertensive subjects. Clin Sci (Lond) 1996, 91:293-298.
59. Shimokubo T, Sakata J, Kitamura K, et al. Adrenomedullin changes in circulating and cardiac tissue concentration in Dahl salt-sensitive rats on a high salt diet. Clin Exp Hypertens 1996, 18:949-961.
60. Nishikimi T, Yoshihara F, Kanazawa A, et al. Role of increased circulating and renal adrenomedullin in rats with malignant hypertension. Am J Physiol Regul Integr Comp Physiol 2001, 281:R2079-R2087.
61. Nishikimi T, Mori Y, Kobayashi N, et al. Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension 2002, 39:1077-1082.
62. Mori Y, Nishikimi T, Kobayashi N, et al. Long-term adrenomedullin infusion improves survival in malignant hypertensive rats. Hypertension 2002, 40:107-113.
63. Chao J, Kato K, Zhang JJ, et al. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides 2001, 22:1731-1737.
64. Dobrzynski E, Wang C, Chao J, et al. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2000, 36:995-1001.
65. Chao J, Jin L, Lin KF, et al. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertens Res 1997, 20:269-277.
66. Nishikimi T, Saito Y, Kitamura K, et al. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 1995, 26:1424-1431.
67. Kobayashi K, Kitamura K, Hirayama N, et al. Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J 1996, 131:676-680.
68. Fabrega E, Casafont F, Crespo J, et al. Plasma adrenomedullin levels in patients with hepatic cirrhosis. Am J Gastroenterol 1997, 92:1901-1904.
69. Guevara M, Gines P, Jimemez W, et al. Increased adrenomedullin levels in cirrhosis: Relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology 1998, 114:336-343.
70. Kojima G, Tsujimoto T, Uemura M, et al. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis. J Hepatol 1998, 28:840-846.
71. Ehlenz K, Koch B, Preuss P, et al. High levels of circulating adrenomedullin in severe illness: Correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp Clin Endocrinol Diabetes 1997, 105:156-162.
72. Hirata Y, Mitaka C, Sato K, et al. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996, 81:1449-1453.
73. Nishio K, Akai Y, Murao Y, et al. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 1997, 25:953-957.
74. Champion HC, Wang R, Shenassa BB, et al. Adrenomedullin induces penile erection in the cat. Eur J Pharmacol 1997, 319:71-75.
75. Kohno M, Yokokawa K, Kano H, et al. Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells. Hypertension 1997, 29:1309-1313.
76. Zhao Y, Hague S, Manek S, et al. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endothelium. Oncogene 1998, 16:409-415.
77. Dennis T, Fournier A, Cadieux A, et al. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in the brain and periphery. J Pharmacol Exp Ther 1990, 254:123-128.
78. Nuki C, Kawasaki H, Kitamura K, et al. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 1993, 196:245-251.
79. Entzeroth M, Doods HN, Wieland HA, et al. Adrenomedullin mediates vasodilation via CGRP1 receptors. Life Sci 1995, 56:L19-L25.
80. Poyner DR, Taylor GM, Tomlinson AE, et al. Characterization of receptors for calcitonin gene-related peptide and adrenomedullin on the guinea pig vas deferens. Br J Pharmacol 1999, 126:1276-1282.
81. Coppock HA, Owji AA, Austin C, et al. Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin gene-related peptide receptors, which mediate increased intracelluar cAMP and inhibit mitogen-activated protein kinase activity. Biochem J 1999, 338:15-22.
82. Nandha KA, Taylor GM, Smith DM, et al. Specific adrenomedullin binding sites and hypotension in the rat systemic vascular bed. Regul Pept 1996, 62:145-151.
83. Pinto A, Sekizawa K, Yamaya M, et al. Effects of adrenomedullin and calcitonin gene-related peptide on airway and pulmonary vascular smooth muscle in guinea pigs. Br J Pharmacol 1996, 119:1477-1483.
84. Hjelmqvist H, Keil R, Mathai M, et al. Vasodilation and glomerular binding of adrenomedullin in rabbit kidney are not CGRP receptor mediated. Am J Physiol 1997, 273:R716-R724.
85. Eguchi S, Hirata Y, Kano H, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994, 340:226-230.
86. Ishizaka Y, Tanaka M, Kitamura K, et al. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994, 200:642-646.
87. Owji AA, Smith DM, Coppock HA, et al. An abundant and specific binding site for he novel vasodilator adrenomedullin in the rat. Endocrinology 1995, 136:2127-2134.
88. Disa J, Dang K, Tan KB, et al. Interaction of adrenomedullin with calcitonin receptor in cultured human breast cancer cells, T 47D Peptides 1998, 19:247-251.
89. Muff R, Leuthauser K, Buhlmann N, et al. Receptor activity modifying proteins regulate the activity of a calcitonin gene-related peptide receptor in rabbit aortic endothelial cells. FEBS Lett 1998, 441:366-368.
90. Dogan A, Suzuki Y, Koketsu N, et al. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1997, 17:19-25.
91. Eguchi S, Hirata Y, Iwasaki H, et al. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 1994, 135:2454-2458.
92. Nishikimi T, Horio T, Yoshihara F, et al. Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes. Eur J Pharmacol 1998, 353:337-344.
93. Champion HC, Santiago JA, Murphy WA, et al. Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat. Am J Physiol 1997, 272:R234-R242.
94. Foord SM, Marshall FH RAMPs: Accessory proteins for seven transmembrane domain receptors. Trends Pharmacol Sci 1999, 20:184-187.
95. Evans BN, Rosenblatt MI, Mnayer LO, et al. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 2000, 275:31438-31443.